• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Curr Med Imaging . Clinical characteristics and CT imaging features of COVID-19 on admission: A retrospective study

tetano

Editor, Senior Moderator
Curr Med Imaging


. 2021 Feb 17.
doi: 10.2174/1573405617666210218093549. Online ahead of print.
Clinical characteristics and CT imaging features of COVID-19 on admission: A retrospective study


Changchun Liu[SUP] 1 [/SUP], Jianping Cai[SUP] 2 [/SUP], Mengmeng Zhang[SUP] 1 [/SUP], Huizhen Li[SUP] 1 [/SUP], Chunyan Liu[SUP] 1 [/SUP], Jian Dong[SUP] 3 [/SUP], Jinghui Dong[SUP] 1 [/SUP]



Affiliations

Abstract

Background and aims: Coronavirus disease 2019 (COVID-19) pandemic has become a global health issue. This study aimed to explore the clinical characteristics and CT imaging features of patients with COVID-19 on admission.
Methods: Consecutive patients with laboratory-confirmed COVID-19 were retrospectively recruited to this study from January 2020 to March 2020. According to the disease severity status on admission, patients were divided into two groups, the common group and the severe group.
Results: Forty-four patients (F/M 20/24) confirmed with COVID-19 were enrolled in this study. The most common onset symptom was fever (90.9%), followed by cough (43.2%). As for the laboratory tests, common findings included increased C reactive protein (47.7%) and erythrocyte sedimentation rate (43.2%), and decreased lymphocyte (34.1%). Frequency of decreased lymphocyte count and increased lactate dehydrogenase were higher in the severe group (n=14) than in the common group (n=30). About 86% patients showed typical imaging findings of COVID-19 infection including ground-glass opacity with ill-defined margins, air bronchogram, interlobular septal thickening, and consolidation. Lesions mainly located peripherally and subpleurally with diffuse distribution and multiple lung lobes affected.
Conclusion: Fever and cough are the most common onset symptoms of COVID-19. Increased C reactive protein and erythrocyte sedimentation rate were the most common laboratory findings. Typical signs of chest CT imaging of COVID-19 included ground-glass opacity with ill-defined margins, air bronchogram, interlobular septal thickening, and consolidation.

Keywords: COVID-19; Clinical; Computed tomography; Pneumonia.
 
Back
Top Bottom